Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE)

Status: Recruiting
Location: See all (7) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to find out whether the Integrative Medicine at Home (IM@Home) program can help reduce patients' symptoms (such as tiredness, pain, or insomnia) and improve their satisfaction with treatment for their disease. The IM@Home program offers virtual (online rather than in-person) group classes focusing on mind-body practice. Mind-body practice is a health practice that combines mental focus, controlled breathing, and body movements to help relax the body and mind.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• Age ≥ 18 years or older

• Patients with a diagnosis of head and neck tumors, thoracic tumors, gynecological tumors, melanoma, or breast cancer

• Actively receiving systemic oncological treatment or radiotherapy

• Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale)

• Karnofsky score 60 or greater

• Life expectancy greater than six months

• English speaking

Locations
United States
New Jersey
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Recruiting
Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Recruiting
Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Recruiting
Montvale
New York
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities)
Recruiting
Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Recruiting
Harrison
Memorial Sloan Kettering Cancer Center
Recruiting
New York
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Recruiting
Uniondale
Contact Information
Primary
Jun Mao, MD, MSCE
maoj@mskcc.org
646-888-0863
Backup
Tony Hung, MD
HungT@mskcc.org
646-608-4127
Time Frame
Start Date: September 20, 2021
Estimated Completion Date: September 20, 2023
Participants
Target number of participants: 200
Treatments
Experimental: IM@Home
Participants with head and neck tumors, thoracic tumors, gynecological tumors, melanoma, or breast cancer
Placebo Comparator: Enhanced usual care
Participants with head and neck tumors, thoracic tumors, gynecological tumors, melanoma, or breast cancer
Authors
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials